We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDH
RNS Number : 5649F
Immunodiagnostic Systems Hldgs PLC
28 July 2016
Results of AGM
Immunodiagnostic Systems Holdings PLC 28 July 2016
28 July 2016
Immunodiagnostic Systems Holdings plc
Results of AGM
Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, announces the results of its Annual General Meeting (the "Meeting") that was held at 12 noon today.
Trading Update
At the meeting the Chairman, Dr Burkhard Wittek, provided a business update at the Meeting and a copy of the statement has been made available on the Company's website.
Voting Results
All resolutions put to the Meeting were decided on a show of hands and all were duly passed.
For information, details of the proxy voting are shown below:
Resolution Votes For Votes For Votes Against Votes Withheld (as % of (as % of votes cast) votes cast) ---------------------------------- ----------- ------------- -------------- --------------- 1. To receive the accounts for the year ended 31 March 2016 together with the report of the Directors and of the Auditor thereon. 13,731,734 100% 0 0 ---------------------------------- ----------- ------------- -------------- --------------- 2. To declare a final dividend for the year ended 31 March 2016. 13,731,734 100% 0 0 ---------------------------------- ----------- ------------- -------------- --------------- 3. To elect as a director of the Company Mr Paul James Martin. 13,730,148 99.99% 0.01% 0 ---------------------------------- ----------- ------------- -------------- --------------- 4. To elect as a director of the Company Dr Klaus Peter Kaspar. 13,730,148 99.99% 0.01% 0 ---------------------------------- ----------- ------------- -------------- --------------- 5. To elect as a director of the Company Mr Roland Sackers. 13,730,148 99.99% 0.01% 0 ---------------------------------- ----------- ------------- -------------- --------------- 6. To elect as a director of the Company Mr Till Campe. 13,726,648 99.96% 0.04% 0 ---------------------------------- ----------- ------------- -------------- --------------- 7. To re-appoint Ernst & Young LLP as Auditor of the Company. 13,730,148 99.99% 0.01% 0 ---------------------------------- ----------- ------------- -------------- --------------- 8. To authorize the Directors of the Company to determine the remuneration of the Auditor of the Company. 13,731,734 100% 0 0 ---------------------------------- ----------- ------------- -------------- --------------- 9. To approve the Directors' Remuneration Report for the financial year ended 31 March 2016. 13,724,798 99.95% 0.05% 50 ---------------------------------- ----------- ------------- -------------- --------------- 10. To authorise the Directors to allot relevant securities. 13,730,148 99.99% 0.01% 0 ---------------------------------- ----------- ------------- -------------- --------------- 11. To authorise the disapplication of pre-emption rights in accordance with section 570 of the Companies Act 2006. 13,716,734 99.89% 0.11% 0 ---------------------------------- ----------- ------------- -------------- --------------- 12. To authorise the Directors to make market purchases. 13,731,734 100% 0 0 ---------------------------------- ----------- ------------- -------------- ---------------
The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).
For further information:
Immunodiagnostic Systems Holdings plc Tel : +44 (0)191 5190660
Patricio Lacalle, Chief Executive Officer
Paul Martin, Group Finance Director
Peel Hunt LLP Tel : +44 (0)207 418 8900
James Steel
Oliver Jackson
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSELFLAFMSEFW
(END) Dow Jones Newswires
July 28, 2016 10:18 ET (14:18 GMT)
1 Year Immunodiagnostic Systems Chart |
1 Month Immunodiagnostic Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions